General Accident Insurance Company Jamaica Limited (JMSE:GENAC)
Jamaica · Delayed Price · Currency is JMD 5.15
0.00 (0.00%)
At close: Aug 4, 2025
bluebird bio Income Statement
Financials in millions JMD. Fiscal year is January - December.
Millions JMD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Premiums & Annuity Revenue | 11,885 | 11,427 | 8,576 | 6,667 | 3,033 | 2,741 | Upgrade |
Total Interest & Dividend Income | 313.15 | 238.76 | 222.19 | 254.18 | 219.72 | 238.11 | Upgrade |
Gain (Loss) on Sale of Investments | 43.18 | 43.18 | -2.87 | 131.1 | - | - | Upgrade |
Other Revenue | - | - | - | - | 909.08 | 777.67 | Upgrade |
| 12,241 | 11,709 | 8,795 | 7,052 | 4,162 | 3,790 | Upgrade | |
Revenue Growth (YoY) | 33.74% | 33.13% | 24.72% | 69.45% | 9.79% | 14.60% | Upgrade |
Policy Benefits | 11,637 | 11,178 | 7,880 | 6,047 | 1,751 | 1,817 | Upgrade |
Policy Acquisition & Underwriting Costs | - | - | - | - | 511.03 | 465.63 | Upgrade |
Selling, General & Administrative | 38.99 | 38.99 | 36.26 | 33.17 | 1,583 | 1,228 | Upgrade |
Other Operating Expenses | 165.97 | 190.7 | 233.92 | 161.23 | 164.66 | 116.74 | Upgrade |
Total Operating Expenses | 11,841 | 11,408 | 8,150 | 6,242 | 4,010 | 3,627 | Upgrade |
Operating Income | 399.72 | 301.1 | 645.25 | 810.1 | 151.6 | 163.23 | Upgrade |
Interest Expense | - | - | - | - | -7.4 | -8.43 | Upgrade |
Currency Exchange Gain (Loss) | -22.98 | -22.98 | 70.08 | 2.93 | 102.09 | 80.84 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | - | 0.33 | -0.41 | Upgrade |
EBT Excluding Unusual Items | 376.74 | 278.13 | 715.33 | 813.04 | 246.62 | 235.24 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 1.17 | 0.32 | 6.27 | 2.49 | Upgrade |
Asset Writedown | 21.54 | 21.54 | 24 | 77.97 | 6.8 | 21.81 | Upgrade |
Pretax Income | 398.28 | 299.67 | 740.5 | 891.33 | 259.7 | 259.54 | Upgrade |
Income Tax Expense | 55.31 | 51.34 | 192.23 | 110.94 | 110.46 | 65.72 | Upgrade |
Earnings From Continuing Ops. | 342.97 | 248.32 | 548.27 | 780.39 | 149.24 | 193.81 | Upgrade |
Minority Interest in Earnings | -13.22 | -6.99 | -8.09 | -49.65 | 105.51 | 48.69 | Upgrade |
Net Income | 329.75 | 241.33 | 540.18 | 730.74 | 254.75 | 242.5 | Upgrade |
Net Income to Common | 329.75 | 241.33 | 540.18 | 730.74 | 254.75 | 242.5 | Upgrade |
Net Income Growth | -38.54% | -55.32% | -26.08% | 186.85% | 5.05% | -56.60% | Upgrade |
Shares Outstanding (Basic) | 1,011 | 1,031 | 1,031 | 1,031 | 1,031 | 1,031 | Upgrade |
Shares Outstanding (Diluted) | 1,011 | 1,031 | 1,031 | 1,031 | 1,031 | 1,031 | Upgrade |
EPS (Basic) | 0.33 | 0.23 | 0.52 | 0.71 | 0.25 | 0.24 | Upgrade |
EPS (Diluted) | 0.33 | 0.23 | 0.52 | 0.71 | 0.25 | 0.24 | Upgrade |
EPS Growth | -35.41% | -55.32% | -26.08% | 186.85% | 5.05% | -56.60% | Upgrade |
Free Cash Flow | 1,284 | 994.2 | 150.26 | -426.49 | -382.55 | -333.2 | Upgrade |
Free Cash Flow Per Share | 1.27 | 0.96 | 0.15 | -0.41 | -0.37 | -0.32 | Upgrade |
Dividend Per Share | 0.218 | 0.218 | 0.196 | 0.243 | 0.191 | 0.216 | Upgrade |
Dividend Growth | 11.09% | 11.09% | -19.17% | 27.41% | -11.68% | 56.01% | Upgrade |
Operating Margin | 3.26% | 2.57% | 7.34% | 11.49% | 3.64% | 4.31% | Upgrade |
Profit Margin | 2.69% | 2.06% | 6.14% | 10.36% | 6.12% | 6.40% | Upgrade |
Free Cash Flow Margin | 10.49% | 8.49% | 1.71% | -6.05% | -9.19% | -8.79% | Upgrade |
EBITDA | 498.41 | 394.36 | 734.24 | 882.43 | 220.79 | 225.39 | Upgrade |
EBITDA Margin | 4.07% | 3.37% | 8.35% | 12.51% | 5.31% | 5.95% | Upgrade |
D&A For EBITDA | 98.69 | 93.25 | 88.98 | 72.33 | 69.19 | 62.16 | Upgrade |
EBIT | 399.72 | 301.1 | 645.25 | 810.1 | 151.6 | 163.23 | Upgrade |
EBIT Margin | 3.26% | 2.57% | 7.34% | 11.49% | 3.64% | 4.31% | Upgrade |
Effective Tax Rate | 13.89% | 17.13% | 25.96% | 12.45% | 42.53% | 25.32% | Upgrade |
Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.